Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

Dermapharm Holding SE Active

Pharmaceutical Products


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of Dermapharm Holding SE

According to Dermapharm Holding SE latest financial report submitted on 2023-12-31, the company has a Turnover of €1B, Gross-Profit of €719M while the Cash is €159M. Compared with the previous year, the company reported a Turnover increase of 9.74%, which is an equivalent of 1.2 billion. At the same time, the Gross-Profit went up by 8.11%, or by 777.5 million.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Access 20 Years of Financial Data

Upgrade plan
  • Reporting period

    12

  • Consolidated A/cs

    Y

  • Profit after Tax

    € 60.5 million

  • Working Capital

    € 236.0 million

Profit after Tax

Business Credit Report

A Credit Report Dermapharm Holding SE is available for instant download. When we generate this report, we took into account that the company is 8 year old, Turnover €1B, Gross-Profit €719M and the Cash of €159M. Next, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, is considered a high level of corporate failures.


Overall Credit Risk for

Dermapharm Holding SE

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

Employees

Dermapharm Holding SE currently employees 13 people. The management level consists of 0.00% of manager level, 0.00% of senior level, 66.67% of cxo level, 11.11% of director level, 0.00% of vp level, 22.22% of partner level, 0.00% of non-manager level.


Total Employee Count

Total employees

13

Management Level


67

Top

11

Middle

Employee Job Title Email Phone Country
Michael Stellner Referent Konzernrechnungswesen
****************@dermapharm.de
- DE
Thomas Gaffron Apothekenreferent
**************@dermapharm.de
- DE
Pilar Lope Kam Inmunoterapia Alergia Y DermatologíA
**********@dermapharm.de
- DE
Jürgen Ott Member of the Executive Board
-
- DE
Andreas Christian Eberhorn Member of the Executive Board
-
- DE

Get direct emails & phone numbers for senior executives working at «Dermapharm Holding SE»

Build your list of contacts and filter them by job title seniority level, age nationality and export the list to XL, Salesforce or via API

Download Extension

Group Structure

Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Now

Dermapharm Holding SE Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at Dermapharm Holding SE. One of of major shareholders of Dermapharm Holding SE is iShares MSCI EAFE Small Cap ETF, which owns 78213 ORDINARY shares, with a total value of 3,441,372 EUR and Vanguard International Stock Index-Total Intl Stock Indx, which owns 219757 ORDINARY shares, with a total value of 9,669,308 EUR and Financial Investors Tr-Grandeur Peak Global Opportunities Fund, which owns 131338 ORDINARY shares, with a total value of 5,778,872 EUR and Financial Investors Tr-Grandeur Peak International Opportunities Fund, which owns 165476 ORDINARY shares, with a total value of 7,280,944 EUR and iShares Core MSCI EAFE ETF, which owns 96690 ORDINARY shares, with a total value of 4,254,360 EUR.


Name Quantity Share Type Value
iShares MSCI EAFE Small Cap ETF
78213 ORDINARY 3441372 EUR
Vanguard International Stock Index-Total Intl Stock Indx
219757 ORDINARY 9669308 EUR
Financial Investors Tr-Grandeur Peak Global Opportunities Fund
131338 ORDINARY 5778872 EUR
Financial Investors Tr-Grandeur Peak International Opportunities Fund
165476 ORDINARY 7280944 EUR
iShares Core MSCI EAFE ETF
96690 ORDINARY 4254360 EUR

See All Beneficial Owners & Shareholders

Unlock Full Access

Competitors:

Top 5 similar companies of Dermapharm Holding SE are Medios AG. View and export all the competitor list of Dermapharm Holding SE by upgrading your account here.


Medios AG


Revenue
1,784,703,000.0
Age
26 years
Employees
1037
Industry
View Pharmaceutical Products
Website
View https://www.**********

View & Export Competitors:

Get the complete list with detailed profiles

Start Now

Dermapharm Holding SE news & activities:


Turnover

Dermapharm Holding SE has submitted new account statements and has reported a turnover of €1B, a 9.74% decrease year-over-year.

de.globaldatabase.com

2023-12-31

EBITDA

The Dermapharm Holding SE-based company said the adjusted EBITDA is now €266M, compared with the previous year of 201.3 million.

de.globaldatabase.com

2023-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start Now

Frequently Asked Questions regarding Dermapharm Holding SE


Where is Dermapharm Holding SE registered office?

Dermapharm Holding SE is located at Lil-dagover-ring 7, Germany.

How can I contact Dermapharm Holding SE?

You can call Dermapharm Holding SE at the following number +49896*****

What is the website of Dermapharm Holding SE?

Dermapharm Holding SE website is https://dermapharm.de/

How many people work at Dermapharm Holding SE?

According to the latest account statement, there are currently 13 of employees working for Dermapharm Holding SE.

How much revenue does Dermapharm Holding SE make?

Based on the latest financial accounts submitted on 2023-12-31, the company made €1B for 2023, which went up by 9.74%.

What is Dermapharm Holding SE EBITDA?

For 2023, Dermapharm Holding SE has reported an EBITDA of €266M, which went down by -24.2% compared to previous year.

What is the Business Credit Score of Dermapharm Holding SE and how reliable is the company?

In order to check the business credit score of Dermapharm Holding SE, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does Dermapharm Holding SE pay their invoices on time?

By requesting a Business Credit Report for Dermapharm Holding SE, you will be able to gain more insights about the Dermapharm Holding SE payment trends.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Explore API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action